General Anesthesia Drugs Market is expected to be worth US$ 6.7 billion by 2032 | FMI
The General Anesthesia Drugs Market is predicted to be worth US$ 4.7 billion by the end of 2022, and to grow at a CAGR of 3.4% to be worth US$ 6.7 billion by the end of 2032. According to a new analysis by Future Market Insights, the Propofol medication class will top the global market with a share of approximately 25.6% in 2021. Get Full Access: https://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market “Tech advancements in drug delivery apparatus, research on patient monitoring devices, and targeted drugs for patients during and after the use of anesthesia, and reduction of side effects from modern anesthetic drugs are providing impetus to growth of the general anesthesia drugs market,” says the FMI analyst. General Anesthesia Drugs Market – Key Takeaways Propofol is a highly popular general anesthesia drug, aided by low risk of side effects. Injectables remain the common general anesthesia drug delivery method, owing to ...